WFA
LUMO

Wipfli Financial Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Wipfli Financial Advisors’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$9K Buy
+1,011
New +$8.4K ﹤0.01% 1901

Other funds holding LUMO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

Wipfli Financial Advisors's LUMO Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2022: 1,011 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #1901 among its holdings.

35 funds tracked by Wall St. Rank hold LUMO as of Q3 2022.

  • Wipfli Financial Advisors held 1,011 shares of Lumos Pharma, Inc. Common Stock worth $9K as of Q3 2022.
  • Lumos Pharma, Inc. Common Stock was a new Wipfli Financial Advisors position in Q3 2022.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1901 holding.
  • 35 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.